These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 29807223)
1. Microbiome as therapeutics in vesicular delivery. Singhvi G; Girdhar V; Patil S; Gupta G; Hansbro PM; Dua K Biomed Pharmacother; 2018 Aug; 104():738-741. PubMed ID: 29807223 [TBL] [Abstract][Full Text] [Related]
2. Interactions between microbiome and lungs: Paving new paths for microbiome based bio-engineered drug delivery systems in chronic respiratory diseases. Chellappan DK; Sze Ning QL; Su Min SK; Bin SY; Chern PJ; Shi TP; Ee Mei SW; Yee TH; Qi OJ; Thangavelu L; Rajeshkumar S; Negi P; Chellian J; Wadhwa R; Gupta G; Collet T; Hansbro PM; Dua K Chem Biol Interact; 2019 Sep; 310():108732. PubMed ID: 31276660 [TBL] [Abstract][Full Text] [Related]
3. Cyclodextrin inclusion complexes loaded in particles as drug carrier systems. Fraceto LF; Grillo R; Sobarzo-Sánchez E Curr Top Med Chem; 2014; 14(4):518-25. PubMed ID: 24354668 [TBL] [Abstract][Full Text] [Related]
4. Vesicular Systems Containing Curcumin and Their Applications in Respiratory Disorders - A Mini Review. Chellappan DK; Hansbro PM; Dua K; Hsu A; Gupta G; Ng ZY; Wong JY; Chellian J; Panneerselvam J Pharm Nanotechnol; 2017; 5(4):250-254. PubMed ID: 28786351 [TBL] [Abstract][Full Text] [Related]
5. Sugar-based novel niosomal nanocarrier system for enhanced oral bioavailability of levofloxacin. Imran M; Shah MR; Ullah F; Ullah S; Elhissi AM; Nawaz W; Ahmad F; Sadiq A; Ali I Drug Deliv; 2016 Nov; 23(9):3653-3664. PubMed ID: 27886514 [TBL] [Abstract][Full Text] [Related]
6. Combinations of nanovesicles and physical methods for enhanced transdermal delivery of a model hydrophilic drug. Zorec B; Zupančič Š; Kristl J; Pavšelj N Eur J Pharm Biopharm; 2018 Jun; 127():387-397. PubMed ID: 29581043 [TBL] [Abstract][Full Text] [Related]
7. Liposomal drug delivery systems: from concept to clinical applications. Allen TM; Cullis PR Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225 [TBL] [Abstract][Full Text] [Related]
8. PEGylated nanocarriers for systemic delivery. Jain NK; Nahar M Methods Mol Biol; 2010; 624():221-34. PubMed ID: 20217599 [TBL] [Abstract][Full Text] [Related]
9. Immunological axis of curcumin-loaded vesicular drug delivery systems. Chellappan DK; Ng ZY; Wong JY; Hsu A; Wark P; Hansbro N; Taylor J; Panneerselvam J; Madheswaran T; Gupta G; Bebawy M; Hansbro PM; Dua K Future Med Chem; 2018 Apr; 10(8):839-844. PubMed ID: 29620416 [TBL] [Abstract][Full Text] [Related]
10. Novel drug delivery system: an immense hope for diabetics. Rai VK; Mishra N; Agrawal AK; Jain S; Yadav NP Drug Deliv; 2016 Sep; 23(7):2371-2390. PubMed ID: 25544604 [TBL] [Abstract][Full Text] [Related]
11. Delivering natural products and biotherapeutics to improve drug efficacy. Obeid MA; Al Qaraghuli MM; Alsaadi M; Alzahrani AR; Niwasabutra K; Ferro VA Ther Deliv; 2017 Nov; 8(11):947-956. PubMed ID: 29061102 [TBL] [Abstract][Full Text] [Related]
12. The formalism of fractal aggregation phenomena of colloidal drug delivery systems. Pippa N; Demetzos C; Danezis E J Liposome Res; 2012 Mar; 22(1):55-61. PubMed ID: 21774618 [TBL] [Abstract][Full Text] [Related]
13. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system. Bamrungsap S; Zhao Z; Chen T; Wang L; Li C; Fu T; Tan W Nanomedicine (Lond); 2012 Aug; 7(8):1253-71. PubMed ID: 22931450 [TBL] [Abstract][Full Text] [Related]
14. Niosomes in sustained and targeted drug delivery: some recent advances. Azeem A; Anwer MK; Talegaonkar S J Drug Target; 2009 Nov; 17(9):671-89. PubMed ID: 19845484 [TBL] [Abstract][Full Text] [Related]
15. A critical review about methodologies for the analysis of mucoadhesive properties of drug delivery systems. Bassi da Silva J; Ferreira SBS; de Freitas O; Bruschi ML Drug Dev Ind Pharm; 2017 Jul; 43(7):1053-1070. PubMed ID: 28276785 [TBL] [Abstract][Full Text] [Related]
16. Proniosomes derived niosomes: recent advancements in drug delivery and targeting. Khatoon M; Shah KU; Din FU; Shah SU; Rehman AU; Dilawar N; Khan AN Drug Deliv; 2017; 24(sup1):56-69. PubMed ID: 29130758 [TBL] [Abstract][Full Text] [Related]
17. Liposomes in biology and medicine. Schwendener RA Adv Exp Med Biol; 2007; 620():117-28. PubMed ID: 18217339 [TBL] [Abstract][Full Text] [Related]
18. Liposomes and niosomes as topical drug delivery systems. Choi MJ; Maibach HI Skin Pharmacol Physiol; 2005; 18(5):209-19. PubMed ID: 16015019 [TBL] [Abstract][Full Text] [Related]
19. Niosomes as Nano-Delivery Systems in the Pharmaceutical Field. Cerqueira-Coutinho C; Dos Santos EP; Mansur CR Crit Rev Ther Drug Carrier Syst; 2016; 33(2):195-212. PubMed ID: 27651102 [TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir. Akhter S; Kushwaha S; Warsi MH; Anwar M; Ahmad MZ; Ahmad I; Talegaonkar S; Khan ZI; Khar RK; Ahmad FJ Drug Dev Ind Pharm; 2012 Jan; 38(1):84-92. PubMed ID: 21726136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]